Human Genome Epidemiology Literature Finder
Records 1 - 17 (of 17 Records) |
Query Trace: Leukemia and ABCC4[original query] |
---|
Polymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia. Pharmacogenetics and genomics 2013 Feb 23 (2): 53-61. Lopez-Lopez Elixabet, Ballesteros Javier, Piñan Maria A, Sanchez de Toledo José, Garcia de Andoin Nagore, Garcia-Miguel Purificacion, Navajas Aurora, Garcia-Orad Afri |
Thiopurine pharmacogenomics: association of SNPs with clinical response and functional validation of candidate genes. Pharmacogenomics 2014 Mar 15 (4): 433-47. Matimba Alice, Li Fang, Livshits Alina, Cartwright Cher S, Scully Stephen, Fridley Brooke L, Jenkins Gregory, Batzler Anthony, Wang Liewei, Weinshilboum Richard, Lennard Lyn |
Genetic variants in 6-mercaptopurine pathway as potential factors of hematological toxicity in acute lymphoblastic leukemia patients. Pharmacogenomics 2015 Jul 16 (10): 1119-34. Hareedy Mohammad Salem, El Desoky Ehab S, Woillard Jean-Baptiste, Thabet Romany Helmy, Ali Amany Mohamad, Marquet Pierre, Picard Nicol |
MiR-pharmacogenetics of methotrexate in childhood B-cell acute lymphoblastic leukemia. Pharmacogenetics and genomics 2016 Sep . Iparraguirre Leire, Gutierrez-Camino Angela, Umerez Maitane, Martin-Guerrero Idoia, Astigarraga Itziar, Navajas Aurora, Sastre Ana, Garcia de Andoin Nagore, Garcia-Orad Afri |
[Susceptibility to 6-mercaptopurine toxicity related with NUDT15 and ABCC4 variants in Japanese childhood acute lymphoblastic leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology 2017 58 (8): 950-956. Tanaka Yoic |
APEX1 Polymorphism and Mercaptopurine-Related Early Onset Neutropenia in Pediatric Acute Lymphoblastic Leukemia. Cancer research and treatment 2018 Jul 50 (3): 823-834. Kim Hyery, Seo Heewon, Park Yoomi, Min Byung-Joo, Seo Myung-Eui, Park Kyung Duk, Shin Hee Young, Kim Ju Han, Kang Hyoung J |
ABCC4 functional SNP in the 3' splice acceptor site of exon 8 (G912T) is associated with unfavorable clinical outcome in children with acute lymphoblastic leukemia. Cancer chemotherapy and pharmacology 2017 Jul 80 (1): 109-117. Mesrian Tanha Hamzeh, Rahgozar Soheila, Mojtabavi Naeini Marj |
Interaction between NUDT15 and ABCC4 variants enhances intolerability of 6-mercaptopurine in Japanese patients with childhood acute lymphoblastic leukemia. The pharmacogenomics journal 2017 Apr . Tanaka Y, Nakadate H, Kondoh K, Nakamura K, Koh K, Manabe |
SLCO1B1 Polymorphisms are Associated With Drug Intolerance in Childhood Leukemia Maintenance Therapy. Journal of pediatric hematology/oncology 2018 Apr . Eldem ?rem, Yavuz Duygu, Cumao?ullari Özge, ?leri Talia, Ünal ?nce Elif, Ertem Mehmet, Do?anay Erdo?an Beyza, Bindak Recep, Özda? Hilal, ?atiro?lu-Tufan N Lale, Uysal L Zümr |
Variants in TPMT, ITPA, ABCC4 and ABCB1 Genes As Predictors of 6-mercaptopurine Induced Toxicity in Children with Acute Lymphoblastic Leukemia. Journal of medical biochemistry 2019 1 37 (3): 320-327. Milosevic Goran, Kotur Nikola, Krstovski Nada, Lazic Jelena, Zukic Branka, Stankovic Biljana, Janic Dragana, Katsila Theodora, Patrinos George P, Pavlovic Sonja, Dokmanovic Lidi |
Polymorphisms in the CYP2A6 and ABCC4 genes are associated with a protective effect on chronic myeloid leukemia in the Brazilian Amazon population. Molecular genetics & genomic medicine 2021 May e1694. Monte Natasha, Pantoja Karla B C C, Rodrigues Juliana C G, de Carvalho Darlen C, Azevedo Tereza C B, Pereira Esdras E B, de Assumpção Paulo P, Dos Santos Sidney E B, Fernandes Marianne R, Dos Santos Ney P |
Novel risk factors for glucarpidase use in pediatric acute lymphoblastic leukemia: Hispanic ethnicity, age, and the ABCC4 gene. Pediatric blood & cancer 2021 3 68 (8): e29036. Zobeck Mark C, Bernhardt M Brooke, Kamdar Kala Y, Rabin Karen R, Lupo Philip J, Scheurer Michael |
Genetic Variation in ABCC4 and CFTR and Acute Pancreatitis during Treatment of Pediatric Acute Lymphoblastic Leukemia. Journal of clinical medicine 2021 Oct 10 (21): . Bartram Thies, Schütte Peter, Möricke Anja, Houlston Richard S, Ellinghaus Eva, Zimmermann Martin, Bergmann Anke, Löscher Britt-Sabina, Klein Norman, Hinze Laura, Junk Stefanie V, Forster Michael, Bartram Claus R, Köhler Rolf, Franke Andre, Schrappe Martin, Kratz Christian P, Cario Gunnar, Stanulla Mart |
ABCC4, ITPA, NUDT15, TPMT and their interaction as genetic predictors of 6-mercaptopurine intolerance in chinese patients with acute lymphoblastic leukemia. Pediatric hematology and oncology 2021 10 39 (3): 254-266. Fan Paroni O L, Leung Kam-Tong, Chan Kathy Y Y, Leung Alex W K, Lam Grace K S, Chow Terry T W, Cheng Frankie W T, Yuen Liz Y P, Moriyama Takaya, Yang Jun J, Li Chi-Ko |
Effects of cyclophosphamide related genetic variants on clinical outcomes of adult hematopoietic cell transplant patients. Cancer chemotherapy and pharmacology 2022 Jan . Takahashi Takuto, Pearson Rachael, Cao Qing, Scheibner Aileen, Sanghavi Kinjal, Weisdorf Daniel, Brunstein Claudio, Rogosheske John, Bachanova Veronika, Warlick Erica D, Wiseman Anthony, Jacobson Pamala |
NUDT15 is a key genetic factor for prediction of hematotoxicity in pediatric patients who received a standard low dosage regimen of 6-mercaptopurine. Drug metabolism and pharmacokinetics 2022 1 43 100436. Khaeso Kanyarat, Komvilaisak Patcharee, Chainansamit Su-On, Nakkam Nontaya, Suwannaying Kunanya, Kuwatjanakul Pitchayanan, Hikino Keiko, Dornsena Areerat, Kanjanawart Sirimas, Laoaroon Napat, Vannaprasaht Suda, Taketani Takeshi, Tassaneeyakul Wichitt |
Novel and replicated clinical and genetic risk factors for toxicity from high-dose methotrexate in pediatric acute lymphoblastic leukemia. Pharmacotherapy 2023 2 43 (3): 205-214. Zobeck Mark, Bernhardt M Brooke, Kamdar Kala Y, Rabin Karen R, Lupo Philip J, Scheurer Michael |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: